Kresko RNAtech is a biotechnology firm that identifies and stabilizes bioactive RNAs from natural sources using AI-driven bioinformatics. They partner with supplement, beauty, and food companies to integrate these ingredients into products.
Kresko RNAtech is a biotechnology company that develops functional, natural ingredients derived from bioactive RNAs found in medicinal herbs, fungi, and superfoods. The company utilizes a proprietary bioinformatics platform called Serkanto AI, which employs machine learning and deep learning algorithms to rapidly identify, validate, and stabilize these RNA molecules. By preserving the functionality of these compounds, Kresko enables the development of products that remain effective through digestion, allowing for health benefits that include metabolic regulation, anti-inflammatory properties, and epigenetic health support.
The company provides these science-backed ingredients to partners in the supplements, beauty, and functional food sectors, helping them create novel products with a competitive market edge. By offering tailored R&D collaboration and end-to-end integration support, Kresko aims to transform how industries utilize natural resources to address consumer wellness needs. Their work is supported by institutional backing, including investment from IndieBio and SOSV, and they are recognized for pioneering the stabilization of these supernutrients to deliver tangible health outcomes at a cellular level.